Tango Therapeutics, Inc. (TNGX) Misses Q1 EPS by 1c
Get Alerts TNGX Hot Sheet
Join SI Premium – FREE
Tango Therapeutics, Inc. (NASDAQ: TNGX) reported Q1 EPS of ($0.32), $0.01 worse than the analyst estimate of ($0.31).
For earnings history and earnings-related data on Tango Therapeutics, Inc. (TNGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel on FedEx Freight (FDXF): 'Enters Its Post-Breakup Era - Time to Hit the Gym and Focus on Itself'
- Ford CEO aims for a 20% sales jump by 2032 - WSJ
- Anthropic may not secure investment-grade rating after IPO, Blackstone tells investors - FT
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share